Jivora Opportunistic Viral Panel™

Regular price $787.89
Sale price $787.89 Regular price $2,293.40 Bundle Price
Unit price
  • SKU:
    JTPSI006
Ask a question

Ask a Question

* Required fields

Size guide Share

Jivora Opportunistic Viral Panel: Expanded Immune Mapping*

The Jivora Opportunistic Viral Panel is a professional laboratory resource designed to provide a detailed view of the immune markers associated with common viral families. While often secondary in wellness investigations, viruses such as Epstein-Barr (EBV) and Cytomegalovirus (CMV) can provide important context to your overall immunological history.

This home blood collection kit utilizes advanced antibody quantification to help you and your healthcare provider understand your immune response across multiple viral markers.

Who It’s For

This targeted home blood collection kit is a professional resource for:

  • Wellness Investigators: Individuals seeking to establish a comprehensive viral baseline as part of a long-term health strategy.

  • Complex Health Detectives: Those investigating their immunological history following a suspected viral event or period of systemic distress.

  • Proactive Health Strategists: Individuals working with healthcare providers to map out potential environmental viral markers.


What It Measures

This panel offers an in-depth look at four major viral markers:

  • EBV (Epstein-Barr Virus): A comprehensive profile including IgG, IgM, and EBNA markers to provide a detailed view of your immunological history.

  • CMV (Cytomegalovirus): IgG and IgM markers to detect the immune response to this common, persistent virus.

  • VZV (Varicella Zoster Virus): Identification of IgG, IgM, and IgA antibodies, providing a high-resolution look at immune markers associated with this virus.

  • Coxsackievirus (A7/B1): Specialized IgG and IgA screening for these enteroviruses to support a comprehensive wellness profile.

How it works (3 steps):

  • Order
  • Collect at home & return ship 
  • Get results and review next steps


More About Your Jivora Opportunistic Viral Panel™

Convenient Access to Wellness Insights

You can order your testing kit directly through Jivora Health, an authorized ArminLabs partner. Our streamlined online process respects your privacy and security, allowing you to take a proactive role in monitoring your immune health without the need for a prior office visit.

Simple, Needle-Free Collection at Home

Each kit features the FDA-cleared Tasso+ device, designed for easy and virtually painless blood collection from the upper arm. This innovative technology allows you to collect a high-quality sample without traditional needles. If you prefer, a standard clinical blood draw option is also available. Both methods are validated for sample stability and laboratory accuracy.

Informational Results for Better Conversations

Your report provides a detailed look at how your immune system reacts to specific tick-borne antigens. These findings are educational in nature and intended to help you have more informed discussions with your healthcare provider. Please note that these results are not a medical diagnosis and should not be used as a standalone basis for a treatment plan.

Medications and Testing

While most common medications do not impact the results, certain intensive therapies - such as strong immunosuppressants, chemotherapy, or interferon-gamma therapy - may affect your immune system’s natural reactivity. We recommend consulting your clinician before sample collection if you are currently undergoing these treatments.

Fast, Secure, and Supported

Once your sample is received by the laboratory, your secure digital report is typically available within 7 to 10 business days. To help you navigate your findings, Jivora Health provides access to a complimentary educational review to explain the data markers in your report.

Comprehensive Immune Screening

Traditional screenings often focus on a single strain of Borrelia. The ArminLabs approach provides a broader perspective by screening for reactivity to Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. By including persistent-form (round-body) antigens, this test offers a more comprehensive view of your immune profile, reducing the limitations found in narrower testing methods.

Understanding Your Immune Markers

  • IgM Reactivity: Typically associated with a more recent or active immune response.

  • IgG Reactivity: Generally indicates an immune memory or long-term reactivity. ArminLabs calibrates these markers to provide you and your healthcare professional with a clear map of your immune system’s history and current status.

The Science of Antigen Diversity

Borrelia bacteria are known for their ability to shift forms, including "round-body" or pleomorphic states. Because these different forms can trigger different immune responses, our testing includes specific antigens for both active and persistent forms. This multi-antigen approach ensures a more thorough assessment of immune reactivity that standard screenings might overlook.


Regulatory Status: The Tasso+ collection device is FDA-cleared. The laboratory tests provided by ArminLabs are Laboratory Developed Tests (LDTs). These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary for LDTs when performed by a CLIA-certified laboratory.

Educational Use: These results are for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

*This test was developed and its performance characteristics determined by ArminLabs. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is intended for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Technical Information
key fact
The panel includes specialized tests covering 4 specific viruses: three members of the herpesvirus family and one enterovirus. It is a critical diagnostic tool for investigating post-viral illness, chronic fatigue, and immunosuppression, as it distinguishes between active, past, and latent infections to provide a clear picture of viral status.
material
The panel analyzes a blood sample to identify four specific antibody markers:

•IgM: Signals a new or currently reactivating infection.

•IgG: Confirms long-term memory or prior exposure.

•IgA: Indicates mucosal immunity, relevant for viruses entering through the gut or respiratory tract.

•EBNA: A specialized marker used specifically for EBV to identify the latency phase.
further information on the test
The testing structure is divided into two primary categories:

•Herpesvirus Family (HHV): Includes highly detailed profiling for EBV (using EBNA for latency mapping), CMV (monitoring for reactivation risks in pregnancy or suppression), and VZV (using a three-antibody profile to detect shingles reactivation).

•Enterovirus: Screens for Coxsackievirus (A7 / B1) strains, utilizing IgA to reflect mucosal immune memory in the gastrointestinal tract.
further information on the pathogen
The pathogens covered in this panel are known for their ability to establish lifelong latent infections. While they may remain dormant for years, they can "awaken" or reactivate when the host's immune system is compromised. These viruses are linked to a variety of conditions, including glandular fever, shingles, myocarditis, and post-viral fatigue syndrome.

Important:These test results are for informational and educational purposes only. They provide immune response markers and are not intended to diagnose, treat, cure, or prevent any disease. This test should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions based on test results.